Chromatographic separation of three monoclonal antibody variants using multicolumn countercurrent solvent gradient purification (MCSGP)

Multicolumn countercurrent solvent gradient purification (MCSGP) is a continuous chromatographic process developed in recent years (Aumann and Morbidelli, 2007a ; Aumann et al., 2007 ) that is particularly suited for applications in the field of bioseparations. Like batch chromatography, MCSGP is suitable for three‐fraction chromatographic separations and able to perform solvent gradients but it is superior in terms of solvent consumption, yield, purity, and productivity due to the countercurrent movement of the liquid and the solid phases. In this work, the MCSGP process is applied to the separation of three monoclonal antibody variants on a conventional preparative cation exchange resin. The experimental process performance was compared to simulations based on a lumped kinetic model. Yield and purity values of the target variant of 93%, respectively were obtained experimentally. The batch reference process was clearly outperformed by the MCSGP process. Biotechnol. Bioeng. 2008;100: 1166–1177. © 2008 Wiley Periodicals, Inc.

[1]  Massimo Morbidelli,et al.  A semicontinuous 3-column countercurrent solvent gradient purification (MCSGP) process. , 2008, Biotechnology and bioengineering.

[2]  Massimo Morbidelli,et al.  Parametric study of a 6‐column countercurrent solvent gradient purification (MCSGP) unit , 2007, Biotechnology and bioengineering.

[3]  Massimo Morbidelli,et al.  A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process , 2007, Biotechnology and bioengineering.

[4]  Giorgio Carta,et al.  pH transitions in cation exchange chromatographic columns containing weak acid groups. , 2007, Journal of chromatography. A.

[5]  Massimo Morbidelli,et al.  A continuous, counter-current multi-column chromatographic process incorporating modifier gradients for ternary separations. , 2006, Journal of chromatography. A.

[6]  Terrance A Stadheim,et al.  Challenges in therapeutic glycoprotein production. , 2006, Current opinion in biotechnology.

[7]  Gary Walsh,et al.  Biopharmaceuticals: recent approvals and likely directions. , 2005, Trends in biotechnology.

[8]  Massimo Morbidelli,et al.  SMB Operation for Three-Fraction Separations: Purification of Plasmid DNA , 2005 .

[9]  Larry Miller,et al.  Resolution of a racemic pharmaceutical intermediate. A comparison of preparative HPLC, steady state recycling, and simulated moving bed. , 2004, Journal of chromatography. A.

[10]  N Avdalovic,et al.  Protein variant separations by cation-exchange chromatography on tentacle-type polymeric stationary phases. , 1998, Journal of chromatography. A.

[11]  Larry Miller,et al.  Separation of a racemic pharmaceutical intermediate using closed-loop steady state recycling , 1998 .

[12]  Paul Richert,et al.  Applications of simulated moving-bed chromatography to the separation of the enantiomers of chiral drugs , 1997 .

[13]  V. Kasche,et al.  Purification of monoclonal antibodies by simulated moving-bed chromatography. , 1997, Journal of chromatography. A.

[14]  G. Hale,et al.  Repeated cleaning of protein A affinity column with sodium hydroxide. , 1994, Journal of immunological methods.

[15]  Lena Melter Design and optimisation of biochromatographic separation processes , 2006 .

[16]  M Angela Taipa,et al.  Antibodies and Genetically Engineered Related Molecules: Production and Purification , 2004, Biotechnology progress.

[17]  Wei Zhang,et al.  Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms. , 2003, Journal of pharmaceutical and biomedical analysis.

[18]  M. Butler,et al.  Comparisons of the Glycosylation of a Monoclonal Antibody Produced under Nominally Identical Cell Culture Conditions in Two Different Bioreactors , 2000, Biotechnology progress.